Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Labrie

Showing results (31-40 of 110) with videos related to

Pageof 11
Sort By:
Breast Cancer Research and Treatment|March 1, 1995
Inhibitory effect of a steroidal antiestrogen (EM-170) on estrone-stimulated growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the ratF Labrie, S Li, C Labrie, et al.
Endocrinology|December 6, 1997
Morphological changes induced by 6-month treatment of intact and ovariectomized mice with tamoxifen and the pure antiestrogen EM-800A Sourla, S Luo, C Labrie, et al.
Cancer Research|October 16, 1999
Effect of combined treatment with the pure antiestrogen EM-800 and radiotherapy on the growth of human ZR-75-1 breast cancer xenografts in nude miceS Couillard, M Gutman, F Labrie, et al.
Biochemical and Biophysical Research Communications|June 24, 1998
Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancerA Blais, Y Labrie, F Pouliot, et al.
Journal of Steroid Biochemistry|October 1, 1987
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancerC Labrie, L Cusan, M Plante, et al.
Journal of Virology|January 1, 1993
The adenovirus E1A 12S product displays functional redundancy in activating the human proliferating cell nuclear antigen promoterC Kannabiran, G F Morris, C Labrie, et al.
Cancer|February 1, 1993
Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapyF Labrie, A Belanger, J Simard, et al.
Annals of the New York Academy of Sciences|December 29, 1995
DHEA and peripheral androgen and estrogen formation: intracinologyF Labrie, A Bélanger, J Simard, et al.
Neuroendocrinology|December 26, 2001
Effect of long-term treatment with the antiestrogen EM-652.HCl on pituitary estrogen receptor alpha and prolactin mRNA expression in intact, ovariectomized and gonadotropin-releasing hormone-treated female ratsG Pelletier, M El-Alfy, C Labrie, et al.
Brain Research|February 27, 1995
Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the ratR Godbout, P Jelenic, C Labrie, et al.
Pageof 11

Showing results (31-40 of 110) with videos related to

Sort By:
Pageof 11
Breast Cancer Research and Treatment|March 1, 1995
Inhibitory effect of a steroidal antiestrogen (EM-170) on estrone-stimulated growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the ratF Labrie, S Li, C Labrie, et al.
Endocrinology|December 6, 1997
Morphological changes induced by 6-month treatment of intact and ovariectomized mice with tamoxifen and the pure antiestrogen EM-800A Sourla, S Luo, C Labrie, et al.
Cancer Research|October 16, 1999
Effect of combined treatment with the pure antiestrogen EM-800 and radiotherapy on the growth of human ZR-75-1 breast cancer xenografts in nude miceS Couillard, M Gutman, F Labrie, et al.
Biochemical and Biophysical Research Communications|June 24, 1998
Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancerA Blais, Y Labrie, F Pouliot, et al.
Journal of Steroid Biochemistry|October 1, 1987
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancerC Labrie, L Cusan, M Plante, et al.
Journal of Virology|January 1, 1993
The adenovirus E1A 12S product displays functional redundancy in activating the human proliferating cell nuclear antigen promoterC Kannabiran, G F Morris, C Labrie, et al.
Cancer|February 1, 1993
Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapyF Labrie, A Belanger, J Simard, et al.
Annals of the New York Academy of Sciences|December 29, 1995
DHEA and peripheral androgen and estrogen formation: intracinologyF Labrie, A Bélanger, J Simard, et al.
Neuroendocrinology|December 26, 2001
Effect of long-term treatment with the antiestrogen EM-652.HCl on pituitary estrogen receptor alpha and prolactin mRNA expression in intact, ovariectomized and gonadotropin-releasing hormone-treated female ratsG Pelletier, M El-Alfy, C Labrie, et al.
Brain Research|February 27, 1995
Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the ratR Godbout, P Jelenic, C Labrie, et al.
Pageof 11